RGLS
Price
$8.21
Change
-$0.01 (-0.12%)
Updated
Jun 20, 11:57 AM (EDT)
Capitalization
568.41M
53 days until earnings call
SPRY
Price
$15.89
Change
-$0.02 (-0.13%)
Updated
Jun 20, 12:00 PM (EDT)
Capitalization
1.56B
47 days until earnings call
Interact to see
Advertisement

RGLS vs SPRY

Header iconRGLS vs SPRY Comparison
Open Charts RGLS vs SPRYBanner chart's image
Regulus Therapeutics
Price$8.21
Change-$0.01 (-0.12%)
Volume$2.27K
Capitalization568.41M
ARS Pharmaceuticals
Price$15.89
Change-$0.02 (-0.13%)
Volume$512
Capitalization1.56B
RGLS vs SPRY Comparison Chart in %
Loading...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGLS vs. SPRY commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGLS is a Hold and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (RGLS: $8.21 vs. SPRY: $15.91)
Brand notoriety: RGLS and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGLS: 71% vs. SPRY: 206%
Market capitalization -- RGLS: $568.41M vs. SPRY: $1.56B
RGLS [@Biotechnology] is valued at $568.41M. SPRY’s [@Biotechnology] market capitalization is $1.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGLS’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • RGLS’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, RGLS is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGLS’s TA Score shows that 3 TA indicator(s) are bullish while SPRY’s TA Score has 6 bullish TA indicator(s).

  • RGLS’s TA Score: 3 bullish, 5 bearish.
  • SPRY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than RGLS.

Price Growth

RGLS (@Biotechnology) experienced а +0.74% price change this week, while SPRY (@Biotechnology) price change was +10.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

RGLS is expected to report earnings on Aug 12, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.56B) has a higher market cap than RGLS($568M). RGLS YTD gains are higher at: 419.620 vs. SPRY (50.806). SPRY has higher annual earnings (EBITDA): -27.07M vs. RGLS (-47.08M). SPRY has more cash in the bank: 276M vs. RGLS (65.4M). SPRY has less debt than RGLS: SPRY (73K) vs RGLS (1.4M). SPRY has higher revenues than RGLS: SPRY (97.1M) vs RGLS (0).
RGLSSPRYRGLS / SPRY
Capitalization568M1.56B36%
EBITDA-47.08M-27.07M174%
Gain YTD419.62050.806826%
P/E RatioN/A151.25-
Revenue097.1M-
Total Cash65.4M276M24%
Total Debt1.4M73K1,919%
FUNDAMENTALS RATINGS
RGLS: Fundamental Ratings
RGLS
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RGLSSPRY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSSVX7.440.07
+0.95%
AMG Frontier Small Cap Growth N
CSMFX22.890.08
+0.35%
Carillon Scout Mid Cap C
RNGBX55.450.04
+0.07%
American Funds New Economy R2
FLMFX9.24N/A
N/A
Meeder Muirfield Retail
HLEZX18.03-0.01
-0.06%
Harding Loevner Instl Emerg Mkts Z

RGLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGLS has been loosely correlated with ABEO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RGLS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
+0.12%
ABEO - RGLS
45%
Loosely correlated
N/A
ATOS - RGLS
32%
Poorly correlated
-0.90%
NKTX - RGLS
31%
Poorly correlated
+0.55%
NAUT - RGLS
30%
Poorly correlated
+1.06%
SPRY - RGLS
28%
Poorly correlated
+7.35%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+7.35%
LPCN - SPRY
63%
Loosely correlated
+2.23%
ANAB - SPRY
36%
Loosely correlated
-1.81%
RCUS - SPRY
35%
Loosely correlated
-2.18%
AURA - SPRY
35%
Loosely correlated
-1.29%
APGE - SPRY
34%
Loosely correlated
-1.15%
More